Latest Insider Transactions at Nutex Health, Inc. (NUTX)
This section provides a real-time view of insider transactions for Nutex Health, Inc. (NUTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nutex Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nutex Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 08
2025
|
Jon Christian Bates Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+16.98%
|
$81,000
$81.81 P/Share
|
|
Apr 04
2025
|
Kelvin Spears Director |
SELL
Payment of exercise price or tax liability
|
Direct |
34
-0.11%
|
$2,448
$72.1 P/Share
|
|
Apr 04
2025
|
Joshua De Tillio Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
452
-6.52%
|
$32,544
$72.1 P/Share
|
|
Apr 04
2025
|
Pamela W. Montgomery Chief Legal Officer-Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
290
-11.04%
|
$20,880
$72.1 P/Share
|
|
Apr 04
2025
|
Michael L. Chang Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
266
-0.33%
|
$19,152
$72.1 P/Share
|
|
Apr 04
2025
|
Thomas T. Vo Chief Executive Officer |
BUY
Payment of exercise price or tax liability
|
Indirect |
895
+0.05%
|
$64,440
$72.1 P/Share
|
|
Apr 04
2025
|
Warren Hosseinion President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,072
-23.85%
|
$77,184
$72.1 P/Share
|
|
Apr 04
2025
|
Elisa V Luqman Chief Legal Officer - SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
266
-19.91%
|
$19,152
$72.1 P/Share
|
|
Mar 01
2025
|
Jon Christian Bates Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,611
+16.14%
|
-
|
|
Mar 01
2025
|
Kelvin Spears Director |
BUY
Exercise of conversion of derivative security
|
Direct |
143
+0.44%
|
-
|
|
Mar 01
2025
|
Joshua De Tillio Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,125
+23.46%
|
-
|
|
Mar 01
2025
|
Pamela W. Montgomery Chief Legal Officer-Healthcare |
BUY
Exercise of conversion of derivative security
|
Direct |
1,361
+32.28%
|
-
|
|
Mar 01
2025
|
Michael L. Chang Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,250
+1.51%
|
-
|
|
Mar 01
2025
|
Thomas T. Vo Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
5,000
+0.27%
|
-
|
|
Mar 01
2025
|
Warren Hosseinion President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,776
+45.66%
|
-
|
|
Mar 01
2025
|
Elisa V Luqman Chief Legal Officer - SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+48.34%
|
-
|
|
Jan 08
2025
|
Thomas T. Vo Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
5,000
+0.27%
|
-
|
|
Aug 22
2024
|
Jon Christian Bates Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,350
+37.22%
|
$28,350
$21.46 P/Share
|
|
Aug 20
2024
|
Joshua De Tillio Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
575
+10.68%
|
$9,775
$17.4 P/Share
|
|
Aug 19
2024
|
Joshua De Tillio Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,300
+23.5%
|
$22,100
$17.85 P/Share
|
|
Jul 12
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
22,709
+1.23%
|
-
|
|
Jun 12
2024
|
Joshua De Tillio Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+40.54%
|
$0
$0.54 P/Share
|
|
May 30
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
2,986
+0.02%
|
$0
$0.66 P/Share
|
|
May 29
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
3,768
+0.02%
|
$0
$0.68 P/Share
|
|
May 28
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
48,394
+0.27%
|
$0
$0.7 P/Share
|
|
May 13
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
17,330
+0.1%
|
$0
$0.69 P/Share
|
|
Mar 12
2024
|
Jon Christian Bates Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
49,505
+26.26%
|
-
|
|
Mar 12
2024
|
Pamela W. Montgomery Chief Legal Officer-Healthcare |
BUY
Exercise of conversion of derivative security
|
Direct |
16,502
+26.83%
|
-
|
|
Nov 20
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
275,200
+0.1%
|
$0
$0.23 P/Share
|
|
Nov 17
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
224,800
+0.08%
|
$0
$0.23 P/Share
|
|
Nov 15
2023
|
Joshua De Tillio Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
140,000
+50.0%
|
$0
$0.24 P/Share
|
|
Sep 22
2023
|
Warren Hosseinion President |
SELL
Bona fide gift
|
Direct |
141,000
-56.7%
|
-
|
|
Aug 31
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
152,326
+0.06%
|
$0
$0.28 P/Share
|
|
Aug 30
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
305,947
+0.11%
|
$0
$0.31 P/Share
|
|
Aug 29
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
342,744
+0.13%
|
$0
$0.3 P/Share
|
|
Aug 28
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
198,983
+0.07%
|
$0
$0.28 P/Share
|
|
Jun 15
2023
|
Jon Christian Bates Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+18.26%
|
$0
$0.42 P/Share
|
|
Jun 14
2023
|
Mitchell Creem Director |
BUY
Open market or private purchase
|
Indirect |
50,000
+37.95%
|
$0
$0.43 P/Share
|
|
Jun 14
2023
|
Pamela W. Montgomery Chief Legal Officer-Healthcare |
BUY
Open market or private purchase
|
Direct |
12,000
+29.63%
|
$0
$0.43 P/Share
|
|
Jun 13
2023
|
Cheryl Yvonne Grenas Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$0
$0.43 P/Share
|
|
Jun 13
2023
|
Michael Lee Reed Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$0
$0.43 P/Share
|
|
May 26
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
18,028
+0.01%
|
$0
$0.49 P/Share
|
|
May 25
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
482,088
+0.18%
|
$0
$0.49 P/Share
|
|
May 19
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
385,000
+0.14%
|
$0
$0.58 P/Share
|
|
May 18
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
114,884
+0.04%
|
$0
$0.48 P/Share
|
|
May 18
2023
|
John J Waters Director |
BUY
Open market or private purchase
|
Direct |
50,000
+20.3%
|
$0
$0.47 P/Share
|
|
Apr 01
2023
|
Jon Christian Bates Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,505
+36.17%
|
-
|
|
Apr 01
2023
|
Pamela W. Montgomery Chief Legal Officer-Healthcare |
BUY
Exercise of conversion of derivative security
|
Direct |
16,502
+50.0%
|
-
|
|
Dec 13
2022
|
Premier Macy Management Holdings, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
43,880
-0.1%
|
$87,760
$2.06 P/Share
|
|
Dec 12
2022
|
Premier Macy Management Holdings, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
125,498
-0.3%
|
$250,996
$2.21 P/Share
|